Trajectories of fasting glucose and glycated haemoglobin in obese and non-obese incident diabetes: Results from two large cohort studies
Yu HJ, Ho M, Chau PH, Fong DYT
Diabetes Obes Metab. 2023;25(10):2835-2845.
Leggi
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing
Hughes AE, Houghton JAL, Bunce B, et al.
Diabetologia. Pub. online 31 Aug 2023.
Leggi
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes
Meek CL, Stewart ZA, Feig DS, et al.
Diabetologia. Pub. online 24 Aug 2023.
Leggi
Dapagliflozin in patients with heart failure and deterioration in estimate glomerular filtration rate to <25ml/min/1.73m2
Chatur S, Vaduganathan M, Claggett BL, et al.
J Am Coll Cardiol. 2023;S0735-1097(23)06532-4.
Leggi
Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 – a pilot study
Gravda K, Kirste KH, Grzelak K, et al.
BMC Endocr Disord. 2023;23(1):179.
Leggi
Efficacy of dapagliflozin according to geographic location of patients with heart failure
Kondo T, Wang X, Yang M, et al.
J Am Coll Cardiol. 2023;82(10):1014–1026.
Leggi
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
Marx N, Federici M, Schütt K, et al.
European Heart Journal. Pub. online 25 Aug 2023.
Leggi
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
Kosjerina V, Carstensen B, Amadid H, Vistisen D
Diabetologia. Pub. online 28 Jul 2023.
Leggi
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials
Iannone A, Natale P, Palmer SC, et al.
Diabetes Obes Metab. 2023;25(9):2535-2544.
Leggi
Associations of lipoprotein subclasses with risk of all‐cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study
Li R, Chen JX, Lu Q, et al.
Diabetes Obes Metab. Pub. online 26 Jul 2023.
Leggi